Apple Irregular Rhythm Notification Feature Software
Kasutusjuhend
Irregular Rhythm Notification Feature Instructions for Use
Apple Inc. One Apple Park Way Cupertino, CA 95014, USA www.apple.com
KASUTUSNÄITAJAD
The Irregular Rhythm Notification Feature (IRNF) is a software-only mobile medical application that is intended to be used with Apple Watch. The feature analyses pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AF) and provides a notification to the user. The feature is intended for over-the-counter (OTC) use. It is not intended to provide a notification of every episode of irregular rhythm suggestive of AF and the absence of a notification is not intended to indicate no disease process is present; rather, the feature is intended to opportunistically display a notification of possible AF when sufficient data is available for analysis. This data is only captured when the user is still. Along with the users risk factors, the feature can be used to supplement the decision for AF screening. The feature is not intended to replace traditional methods of diagnosis or treatment. The feature has not been tested for and is not intended for use in people under 22 years of age. It is also not intended for use in individuals previously diagnosed with AF.
VENEMAA RIIGITEAVE
Ebaregulaarse rütmi teavitusfunktsiooni ei peeta ROSZDRAVNADZORi (Venemaa tervishoiuameti) järgi meditsiiniseadmeks.
The Irregular Rhythm Notification Feature is a software-only application that is intended to be used with Apple Watch. The feature analyses pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AF) and provides a notification to the user. The feature is intended for over-the-counter (OTC) use. It is not intended to provide a notification of every episode of irregular rhythm suggestive of AF and the absence of a notification is not intended to indicate no disease process is present; rather, the feature is intended to opportunistically display a notification of possible AF when sufficient data is available for analysis. This data is only captured when the user is still. Along with the users risk factors, the feature can be used to supplement the decision for AF screening. The feature is not intended to replace traditional methods of diagnosis or treatment.
The feature has not been tested for and is not intended for use in people under 22 years of age. It is also not intended for use in individuals previously diagnosed with AF.
USING THE IRREGULAR RHYTHM NOTIFICATION FEATURE
Setup/Onboarding
- The Irregular Rhythm Notification Feature is compatible with Apple Watch Series 3, Series 4, Series 5, Series 6, Series 7 and SE. For region availability and device compatibility for the IRNF, please visit https://support.apple.com/HT208931
- Värskendage Apple Watch ja iPhone uusimale operatsioonisüsteemile.
- Avage oma iPhone'is rakendus Health ja valige Sirvi.
- Navigate to Heart, then select Irregular Rhythm Notifications.
- Järgige ekraanil kuvatavaid juhiseid ja viige liitumisprotseduur lõpule.
- Saate liitumisest igal ajal väljuda, puudutades nuppu Tühista.
Teatise saamine
- Once the feature is turned on, you will receive a notification if the feature identified a heart rhythm suggestive of AF and confirmed it on multiple readings.
- If you have not been diagnosed with AF by a medical practitioner, you should discuss the notification with your doctor.
- Kõik ebaregulaarse rütmi teavitusfunktsiooni kogutud ja analüüsitud andmed salvestatakse teie iPhone'i rakendusse Health. Kui soovite, saate seda teavet jagada, eksportides oma terviseandmed rakendusse Health.
- New data cannot be collected once your Apple Watch storage is full. You should free up space by deleting unwanted apps, music or podcasts. You can check your storage usage by navigating to the Apple Watch app on your iPhone, tapping My Watch, tapping General, then tapping Storage.
OHUTUS JA TOIMIVUS
The performance of the Irregular Rhythm Notification Feature (IRNF) was extensively tested in a clinical study of 573 participants aged 22 and older with a mix of diagnosed AF and no known history of AF. Study demographic characteristics are summarized in the table below:
IRNF 2.0 Clinical Study Subject Demographics
Vanusegrupp
<55 123 (21.5%)
>=55 to <65 140 (24.4%)
>=65 310 (54.1%)
Sugu
Male 286 (49.9%)
Female 287 (50.1%)
Rahvus
Hispanic or Latino 38 (6.6%)
Non-Hispanic or Latino 535 (93.4%)
Rass
White 502 (87.6%)
Black or African American 57 (9.9%)
Other 14 (2.4%)
Enrolled subjects wore an Apple Watch and a reference electrocardiogram (ECG) patch concurrently for up to 13 days. For those subjects contributing data to the primary endpoint analysis, 32.4% (n=140/432) presented with AF as identified on the reference ECG patch and were included in determining the device sensitivity. Of those, 124 received an IRNF irregular rhythm notification with concordant AF on the ECG patch, and the sensitivity was 88.6%. Of the 292 subjects who did not present with AF on the ECG patch and contributed data to the analysis of device specificity, 290 did not receive a notification. The AF detection specificity was 99.3%. The remaining subjects (n=141/573) either contributed data to only secondary endpoint analyses and/or did not complete the study. These results support the devices effectiveness in detecting AF.
ETTEVAATUST
Ebaregulaarse rütmi teavitusfunktsioon ei suuda tuvastada südameinfarkti. Kui tunnete kunagi valu rinnus, survet, pigistustunnet või teie arvates südamerabandust, helistage kiirabi.
The Irregular Rhythm Notification Feature is not constantly looking for AF and should not be relied on as a continuous monitor. This means the feature cannot detect all instances of AF, and people with AF may not get a notification.
Apple Watch may be unable to collect data when it is in close proximity to strong electromagnetic fields (e.g. electromagnetic anti-theft systems or metal detectors).
A number of factors can impact the ability of the feature to measure your pulse and detect an irregular rhythm suggestive of AF. These include factors like motion, hand and finger movements, environmental factors such as ambient temperature, dark tattoos on the wrist and the amount of blood flow to your skin (which can be reduced by cold temperatures).
DO NOT wear your Apple Watch during a medical procedure (e.g. magnetic resonance imaging, diathermy, lithotripsy, cautery and external defibrillation procedures).
ÄRGE vahetage oma ravimeid ilma arstiga rääkimata.
Ei ole mõeldud kasutamiseks alla 22-aastastele isikutele.
Not intended for use by individuals previously diagnosed with AF.
Selle funktsiooni teatised on potentsiaalsed leiud, mitte südamehaiguste täielik diagnoos. Kõik teatised peaksid olema uuestiviewmeditsiinitöötaja kliiniliste otsuste tegemiseks.
Apple does not guarantee that you are not experiencing an arrhythmia or other health conditions even in the absence of an irregular rhythm notification. You should notify your doctor if you experience any changes to your health.
For best results, charge your Apple Watch regularly and make sure it fits snugly on top of your wrist. The heart rate sensor should stay close to your skin.
See on teade kasutajale ja/või patsiendile, et igast IRNF-seadmega seotud tõsisest vahejuhtumist tuleb teatada tootjale (Apple) ja selle liikmesriigi pädevale asutusele, kus kasutaja ja/või patsient viibib. asutatud.
SECURITY: Apple recommends that you add a passcode (personal identification number [PIN]), Face ID or Touch ID (fingerprint) to your iPhone and a passcode (personal identification number [PIN]) to your Apple Watch to add a layer of security. It is important to secure your iPhone since you will be storing personal health information on it. Users will also receive additional iOS and watchOS update notifications on their iPhone and Apple Watch, and updates are delivered wirelessly, encouraging rapid adoption of the latest security fixes. See “iOS and watchOS Security Guide”, which describes Apples security practices and is available to all our users. For the iOS and watchOS Security Guide, please visit https://support.apple.com/guide/security/welcome/web.
SEADMETE SÜMBOLID
Tootja
Tutvuge kasutusjuhendiga
Meditsiiniseade
099-30417, redaktsioon B, detsember 2021
Dokumendid / Ressursid
 |
Apple Irregular Rhythm Notification Feature Software [pdf] Juhised Irregular Rhythm Notification Feature Software, Rhythm Notification Feature, Notification Feature Software, Feature Software |
viited
-
Apple'i platvormi turvalisus - Apple'i tugi
-
õun
-
Südame terviseteated teie Apple Watchis – Apple'i tugi
-
õun
